NEWS

Stock Talk – Hikal

About Hikal

Hikal is a Flagship Company of Kalyani Group. Hikal offers solutions across the life sciences value chain. Its provide world-class active ingredients, intermediates and R&D services to global pharmaceuticals, animal health, biotech, crop protection and specialty chemicals companies.

Business Model

Manufacturing Units

Hikal has five manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Karnataka (Jigani) and a Research & Technology center at Maharashtra (Pune). Hikal is the first Indian life sciences company to receive the Responsible Care® certification granted by the International Council of Chemical Associations (ICCA).

Financial Performance

Promoters Holding 68.77%  , MF 7.48% , FII 3.55 and Rest Public Holding

Key Areas for Future Investments:

=> Hikal will continue to invest in increasing manufacturing capacity to improve its market share for the legacy products as well as cater to requirements of new APIs under development
=>Safety and regulatory compliance will remain a top priority for the next financial year and they plan to invest further to keep up with the latest global standards
=> Hikal will continue to invest in human restheces as skilled manpower still remains a key factor in the growth.
=>Continued focus on the animal health business and creating the own portfolio of products

=>In terms of added value and new businesses, they are in the process of evaluating formulation development of the product portfolio as a longterm strategy
=>Niche technologies including steroids, oncology and peptides are being evaluated to differentiate Hikal from other suppliers
=>Newer technologies on the process side such as flow reactors, enzymatic processes to improve productivity will be evaluated to improve costs and create a value proposition for the global client base.

Source From BSE, Hikal Official Website, Research Report of Nalanda Security.

Please Give Your Feedback about This Post in Comment Box, Also if You have some Extra News or Information about this stock then Share here on Comments.

Declaimer: I am not SEBI or BSE / NSE Approved Adviser and My suggestion on the above stock are only for Investment, Invest in Above stock after your own Research and take advice from your Investment Adviser. I am not Responsible for any kind of Loss make in above stocks.

If You Like Our Article then Subscribe to Rejems By Email.

For More Article CLICK HERE

 

 

 

Facebook Comments

Comments

comments

1 Comment

  1. Nitesh Mishra

    I like your posts

Leave a Reply

Theme by: Rejems én